Folic acid is prescribed during certain chemotherapy regimens to protect your healthy cells from serious side effects, including severe mouth sores, dangerously low blood counts, and gastrointestinal damage. The reason depends on which chemotherapy drug you’re receiving. With some drugs, folic acid shields normal tissue from collateral damage. With others, a form of folic acid actually makes the cancer treatment work better. Understanding why your oncologist prescribed it can help you take it correctly and consistently.
How Antifolate Drugs Create the Need
Some chemotherapy drugs are classified as “antifolates,” meaning they work by blocking your body’s ability to use folate, a B vitamin essential for cell division. The drug pemetrexed, commonly used in lung cancer and mesothelioma, is one of the most well-known examples. Methotrexate, used in several cancers and autoimmune conditions, is another.
These drugs target rapidly dividing cancer cells, but they can’t perfectly distinguish cancer cells from the healthy cells that also divide quickly, like those lining your mouth, gut, and bone marrow. When your body’s folate stores are low, the drug hits those healthy tissues harder, causing more severe side effects. Folic acid supplementation raises the folate levels in your normal cells, giving them a buffer of protection. Cancer cells don’t benefit from this buffer in the same way because of how they process folate differently at a molecular level. Clinical trials have consistently shown that folic acid supplementation does not reduce the anti-cancer effectiveness of these drugs, even though that was an early concern.
What Folic Acid Prevents
Without folic acid supplementation, antifolate chemotherapy drugs can cause significantly worse side effects. The most common problems include mucositis (painful inflammation and sores in the mouth and digestive tract), nausea, vomiting, and drops in white blood cell and platelet counts that can become life-threatening.
In patients with kidney cancer treated with various targeted therapies, daily folic acid at doses of 1 to 5 mg reduced mucositis severity from an average grade of 2.38 (moderate to severe, interfering with eating) down to 0.88 (minimal or none). That difference is dramatic in terms of daily quality of life. Severe mucositis often forces doctors to lower the chemo dose or stop treatment entirely, so preventing it also helps keep your treatment on schedule.
For methotrexate specifically, folate supplementation reduces gastrointestinal side effects like nausea, vomiting, and abdominal pain by about 26%. It also helps prevent liver enzyme elevations that can signal liver stress.
The Pemetrexed Protocol
If you’re receiving pemetrexed, the FDA requires a specific folic acid schedule. You take 400 to 1,000 micrograms (mcg) of folic acid by mouth once daily, starting at least 7 days before your first infusion. You continue taking it every day throughout treatment and for 21 days after your last dose. This schedule is not optional. Early clinical experience showed that patients who skipped or shortened the lead-in period had dramatically higher rates of toxicity.
Pemetrexed also requires a vitamin B12 injection, typically given once every 9 weeks during treatment. Both B12 and folic acid deficiencies independently predict more severe side effects, so supplementing both vitamins together provides the best protection. Your oncology team will handle the B12 injection at your infusion appointments, but the daily folic acid pill is your responsibility to take at home.
When Folic Acid Boosts the Drug Instead
Not all chemo-related folic acid use is about reducing side effects. In one important scenario, it does the opposite: it makes the chemotherapy stronger. The drug 5-fluorouracil (5-FU), widely used in colorectal and other cancers, is frequently given alongside a form of folic acid called leucovorin (folinic acid). This is administered intravenously as part of the treatment itself, not as a daily supplement you take at home.
Leucovorin works by locking 5-FU more tightly onto its target inside cancer cells. 5-FU disables an enzyme cancer cells need to copy their DNA, and leucovorin stabilizes that bond, making it harder for cancer cells to escape the drug’s effect. Tumor cells grown with folinic acid present were more susceptible to 5-FU in laboratory studies. So in this case, folic acid isn’t protecting you from the drug. It’s making the drug more lethal to the cancer.
Why the Timing Matters
Folic acid needs time to build up in your cells before chemotherapy starts. The 7-day lead-in period for pemetrexed exists because your body needs to absorb, convert, and distribute folate into tissues throughout your body. Starting folic acid on the same day as your infusion doesn’t provide adequate protection. Case reports of patients who received only 5 to 7 days of supplementation before treatment showed that even this shorter window, while better than nothing, still dramatically reduced toxicity compared to no supplementation at all.
Continuing folic acid for 21 days after your final dose matters too. Pemetrexed stays active in your body for some time after infusion, and your healthy cells remain vulnerable during that window. Stopping folic acid the day chemo ends leaves you unprotected during the drug’s tail-end activity.
A Note on Folic Acid and Cancer Risk
You may come across information suggesting folic acid can promote cancer growth, which can feel alarming when you’re taking it during cancer treatment. The concern applies mainly to very high doses of folic acid taken over long periods in people with pre-existing tumors or precancerous lesions, where excess folate could theoretically fuel the rapid cell division that cancer depends on. This is a real area of scientific discussion, but it does not apply to the supervised supplementation your oncologist prescribes alongside chemotherapy. The doses used (400 to 1,000 mcg daily) are within the range of a standard supplement, and clinical trials have not shown reduced anti-cancer effectiveness when folic acid is taken as directed with antifolate drugs.
The bottom line: folic acid during chemo is carefully matched to your specific drug regimen. It either protects your healthy cells from collateral damage or, in the case of 5-FU combinations, amplifies the treatment’s effect on the tumor. Either way, it’s a deliberate, evidence-backed part of your treatment plan, not a generic wellness add-on.